Protons pump inhibitor treatment and lower gastrointestinal bleeding: Balancing risks and benefits

Proton pump inhibitors (PPIs) represent a milestone in the treatment of acid-related diseases, and are the mainstay in preventing upper gastrointestinal bleeding in high-risk patients treated with nonsteroidal anti-inflammatory drugs (NSAIDs) or low-dose aspirin. However, this beneficial effect does...

Descripción completa

Detalles Bibliográficos
Autores principales: Lué, Alberto, Lanas, Angel
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Baishideng Publishing Group Inc 2016
Materias:
Editorial
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5192259/
https://www.ncbi.nlm.nih.gov/pubmed/28082800
http://dx.doi.org/10.3748/wjg.v22.i48.10477

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5192259/
https://www.ncbi.nlm.nih.gov/pubmed/28082800
http://dx.doi.org/10.3748/wjg.v22.i48.10477

Ejemplares similares